Cencora, Inc. COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches.

Amazon, CVS Health and Walgreens — are licking their financial wounds after multibillion-dollar investments in primary care ...

Cherny covers the Healthcare sector, focusing on stocks such as Walgreens Boots Alliance, Hims & Hers Health, and Quest Diagnostics. ;'> Currently, the analyst consensus on Cencora is a Moderate Buy ...

and troubles for peer firm Walgreens. Cramer’s previous remarks about Cencora, Inc. (NYSE:COR) have called the firm a “money machine” no matter what the circumstances are. This time around ...

But Walgreens made $1 billion in profit by cashing out early on some of its shares of Cencora, a pharmaceutical solutions organization, and benefiting from gains from its investment in ...

Walgreens said Thursday that Sycamore will ... and it’s been reducing its stake in the drug distributor Cencora this year to get cash in part to pay down debt. Ultimately, the company has ...

Walgreens Boots Alliance says it has agreed ... and it's been reducing its stake in the drug distributor Cencora this year to get cash in part to pay down debt. Ultimately, the company has to ...

Walgreens said Thursday that Sycamore will ... and it's been reducing its stake in the drug distributor Cencora this year to get cash in part to pay down debt. Ultimately, the company has to ...

He said he was now upgrading the deal to "alive." Also Read: Walgreens Cashes In: Slashes Cencora Stake Again In Debt-Fighting Move The Wall Street report in December, citing people familiar with ...

Walgreens, Johnson & Johnson, Cardinal Health, Allergan and Teva. Court filings blamed McKesson and Cencora, previously AmerisourceBergen, as well as Cardinal Health for failing to identify and ...